A group of researchers would have taken a very important step in the fight against cancer.
When science and medicine unite to fight against evils like cancer waiting for a convincing result can be very long. But sometimes there are strong victories. As now, with the creation of a drug capable of fighting metastasis.
A group of University and University Hospital of Basel; composed of molecular biologists, computational and clinical biologists. He created a drug capable of preventing the formation of metastasis.
The results of his research were published in the most recent edition of Cell phone. Where is it reported how the researchers tested 2,486 compounds; all approved by the Food and Drug Administration (FDA).
To finally find a series of inhibitors unexpectedly; with the capacity to dissociate and combat groups of Circulating Tumor Cells (CTC) that perform the metastasis.
We think of acting differently from common approaches; and we try to identify drugs that do not kill cancer cells, but simply dissociate them.
These are the statements of the main author, Nicola Aceto, Department of Biomedicine at the University of Basel.
It turns out that the strategy of dissociating CTCs was the key. And with that, the cancer could be treated more effectively.
The next step is to conduct clinical trials on patients. But the discovery is encouraging.